We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$20.9B
AUM Growth
+$3.23B
(+18%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
19.82%
Holding
593
New
94
Increased
215
Reduced
210
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NOV
NOV
|
+$121M |
| 2 |
NetEase
NTES
|
+$98.7M |
| 3 |
Viatris
VTRS
|
+$94.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$85.7M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$85.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$146M |
| 2 |
Meta Platforms (Facebook)
META
|
+$85.3M |
| 3 |
Microsoft
MSFT
|
+$78.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$68.7M |
| 5 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.59% |
| 2 | Technology | 13.29% |
| 3 | Financials | 11.96% |
| 4 | Communication Services | 10.26% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
AES
AES
$10.6B
| $3.51M | 0.02% |
264,220
-47,250
| -15% | -$606K |
|
|
ARIA
402
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.47M | 0.02% |
188,570
+116,310
| +161% | +$2.26M |
|
|
TPC
403
Tutor Perini Cor
TPC
$4.51B
| $3.42M | 0.02% |
160,200
| – | – |
|
|
DTV
404
DELISTED
DIRECTV COM STK (DE)
DTV
| $3.39M | 0.02% |
56,730
+12,040
| +27% | +$741K |
|
405
Synopsys
SNPS
$74.5B
| $3.37M | 0.02% |
89,300
-180,173
| -67% | -$6.68M |
|
406
Bunge Global
BG
$22.8B
| $3.32M | 0.02% |
43,778
-15,000
| -26% | -$1.14M |
|
407
Methanex
MEOH
$4.19B
| $3.25M | 0.02% |
63,200
+589
| +0.9% | +$28K |
|
408
IBM
IBM
$204B
| $3.19M | 0.02% |
+18,012
| New | +$3.27M |
|
409
PNC Financial Services
PNC
$99.6B
| $3.16M | 0.02% |
43,671
-670
| -2% | -$50K |
|
410
Thermo Fisher Scientific
TMO
$208B
| $3.11M | 0.01% |
33,750
+5,010
| +17% | +$453K |
|
411
CubeSmart
CUBE
$9.57B
| $3.09M | 0.01% |
172,972
-68,268
| -28% | -$1.16M |
|
412
Hartford Financial Services
HIG
$38.4B
| $3.07M | 0.01% |
+98,600
| New | +$3.08M |
|
413
Sunstone Hotel Investors
SHO
$2.2B
| $3M | 0.01% |
+235,800
| New | +$3.01M |
|
414
Primoris Services
PRIM
$4.64B
| $2.91M | 0.01% |
114,300
-43,000
| -27% | -$974K |
|
|
AVNR
415
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $2.89M | 0.01% |
682,400
| – | – |
|
|
BMR
416
DELISTED
BIOMED REALTY TRUST INC
BMR
| $2.87M | 0.01% |
+154,300
| New | +$3.03M |
|
417
iShares MSCI South Africa ETF
EZA
$533M
| $2.86M | 0.01% |
45,152
-2,580
| -5% | -$156K |
|
|
FSL
418
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $2.83M | 0.01% |
+170,000
| New | +$2.62M |
|
419
Canadian National Railway
CNI
$78B
| $2.83M | 0.01% |
55,800
-19,600
| -26% | -$967K |
|
420
Expedia Group
EXPE
$33.4B
| $2.79M | 0.01% |
+53,897
| New | +$2.88M |
|
|
NSM
421
DELISTED
Nationstar Mortgage Holdings
NSM
| $2.78M | 0.01% |
49,410
-770
| -2% | -$37.5K |
|
|
OREX
422
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.69M | 0.01% |
+43,780
| New | +$2.96M |
|
423
Adtran
ADTN
$769M
| $2.67M | 0.01% |
100,024
-131,500
| -57% | -$3.41M |
|
424
CGI
GIB
$14.5B
| $2.64M | 0.01% |
75,300
+23,500
| +45% | +$766K |
|
|
CCC
425
DELISTED
Calgon Carbon Corp
CCC
| $2.61M | 0.01% |
137,541
-7,968
| -5% | -$143K |
|
Similar funds
Fidelity International's Q3 2013 Portfolio in Review
As of Q3 2013, Fidelity International held 593 positions worth $20.9B, up 18% from $17.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.55B of net new capital in Q3 2013, opening 94 new positions and adding to 215 existing holdings. Its largest new stake was Viatris: 2,677,695 shares worth $102M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $146M trimmed.
- Fidelity International's largest Q3 2013 buy was Viatris: 2,677,695 shares worth $102M.
- Fidelity International added most to NOV in Q3 2013, an estimated $121M increase.
- Fidelity International's biggest Q3 2013 reduction was Pfizer, cutting an estimated $146M.
- Fidelity International fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $58.5M.
- Fidelity International's ten largest holdings make up 20% of its $20.9B portfolio in Q3 2013.
- Fidelity International opened 94 new positions and closed 50 in Q3 2013.
- Fidelity International's portfolio value rose 18% quarter-over-quarter to $20.9B.
Based on Fidelity International's 13F filing for Q3 2013, filed 14 Nov 2013.